1 |
Wang, Y., Cao, J., Zeng, S., 2005. Involvement of P-glycoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetin. J. Pharm. Pharmacol. 57, 751-758.
DOI
ScienceOn
|
2 |
Wang, Y., Cao, J., Zeng, S., Inramonti, G., Donati, A., Chieli, E., 2004. Effects of grapefruit juice on the multidrug transporter P-glycoprotein in the human proximal tubular cell line HK-2. Life Sci. 76, 293-302.
DOI
|
3 |
Watkins, P.B., 1996. The barrier function of CYP3A4 and P-glycoprotein in the small bowel. Adv. Pharm. Drug Deliv. Rev. 27, 161-170.
|
4 |
Piao, Y., Shin, S.C., Choi, J.S., 2008. Effects of oral kaempferol on the pharmacokinetics of tamoxifen and one of its metabolites, 4-hydroxytamoxifen, after oral administration of tamoxifen to rats. Biopharm. Drug Dispos. 29, 245-249.
DOI
|
5 |
Qian, M., Gallo, J.M., 1992. High-perfomance liquid chromatographic determinination of the calcium channel blocker nimodipine in monkey plasma. J. Chromatogr. 578, 316-320.
DOI
|
6 |
Ramsch, K.D., Ahr, G., Tettenborn, D., Auer, L.M., 1985. Overview on pharmacokinetics of nimodipine in healthy volunteer and in patients with subarachnoid hemorrhage. Neurochirurgia 28, 74-78.
|
7 |
Saeki, T., Ueda, K., Tanigawara, Y., Hori, R., Komano, T., 1993. Pglycoprotein- mediated transcellular transport of MDR-reversing agents. FEBS Lett. 324, 99-102.
DOI
|
8 |
Scherling, D., Buhner, K., Krause, H.P., Karl, W., Wunsche, C., 1991. Biotransformation of nimodipine in rat, dog and monkey. Arzneimittelforschung 41, 392-398.
|
9 |
Scholz, H., 1997. Pharmacological aspects of calcium channel blockers. Cardiovasc. Drugs Ther. 10, 869-872.
DOI
|
10 |
Suwelack, D., Weber, H., Maruhn, D., 1985. Pharmacokinetics of nimodipine, communication: absorption, concentration in plasma and excretion after single administration of nimodipine in rat, dog and monkey. Arzneimittelforschung 35, 1787-1794.
|
11 |
Takino, Y., Miyahara, T., Arichi, E., Arichi, S., Hayashi, T., Karikura, M., 1987. Determination of some flavonoids in Scutellariae radix by high-performance liquid chromatography. Chem. Pharm. Bull. 35, 3494-3497.
DOI
|
12 |
Wacher, V.J., Silverman, J.A., Zhang, Y., Benet, L.Z., 1998. Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. J Pharm Sci, 87, 1322-1330.
DOI
|
13 |
Kelly, P.A., Wang, H., Napoli, K.L., Kahan, B.D., Strobel, H.W., 1999. Metabolism of cyclosporine by cytochromes P450 3A9 and 3A4. Eur. J. Drug Metab. Pharmacokinet. 24, 321-328.
DOI
|
14 |
Maruhn, D., Siefert, H.M., Weber, H., Ramsch, K., Suwelack, D., 1985. Pharmacokinetics of nimodipine. communication: absorption, concentration in plasma and excretion after single administration of nimodipine in rat, dog and monkey. Arzneimittelforschung 5, 1781-1786.
|
15 |
Lee, H., Wang, H.W., Su, H.Y., Hao, N.J., 1994. The structureactivity relationships of flavonoids as inhibitors of cytochrome P-450 enzymes in rat liver microsomes and the mutagenicity of 2-amino-3-methyl-imidazo[4, 5-f]quinoline. Mutagenesis 9, 101-106.
DOI
|
16 |
Lewis, D.F.V., 1996. Cytochrome P450. Substrate specificity and metabolism. In: Cytochromes P450. Structure, Function, and Mechanism. Taylor & Francis: Bristol. 122-123.
|
17 |
Li, C., Li, X., Choi, J.S., 2009. Enhanced bioavailability of etoposide after oral or intravenous administration with kaempferol in rats. Arch.Pharm. Res. 32, 133-138.
과학기술학회마을
DOI
|
18 |
Miean, K.H., Mohamed, S., 2001. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J. Agric. Food Chem. 49, 3106-3112.
DOI
|
19 |
Nijveldt, R.J., van Nood, E., van Hoorn, D.E., Boelens, P.G., van Norren, K., van Leeuwen, P.A., 2001. Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 74, 418-425.
|
20 |
Pal, D., Mitra, A.K., 2006. MDR- and CYP3A4-mediated drugherbal interactions. Life Sci. 78, 2131-2145.
DOI
|
21 |
Patel, J., Buddha, B., Dey, S., Pal, D., Mitra, A.K., 2004. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity. Am. J. Ther. 11, 262-277.
DOI
|
22 |
Dixon, R.A., Steel, C.L., 1999. Flavonoids and isoflavonoids - a gold mine for metabolic engineering. Trend Plant Sci. 4, 394-400.
DOI
|
23 |
Choi, J.S., Burm, J.P., 2006. Enhanced nimodipine bioavailability after oral administration of nimodipine with morin, a flavonoid, in rabbits. Arch. Pharm. Res. 29, 333-338.
과학기술학회마을
DOI
|
24 |
Crespi, C.L., Miller, V.P., Penman, B.W., 1997. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal. Biochem. 248, 188-190.
DOI
|
25 |
Di Pietro, A., Conseil, G., Pérez-Victoria, J.M., Dayan, G., Baubichon- Cortay, H., Trompier, D., Steinfels, E., Jault, J.M., de Wet, H., Maitrejean, M., Comte, G., Boumendjel, A., Mariotte, A.M., Dumontet, C., McIntosh, D.B., Goffeau, A., Castanys, S., Gamarro, F., Barron, D., 2002. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cell Mol. Life Sci. 59, 307-322.
DOI
|
26 |
Epstein, M., Loutzenhister, R.D., 1990. Effects of calcium antagonists on renal hemodynamics. Am. J. Kidney Dis. 16, 10-14.
|
27 |
Gan, L.L., Moseley, M.A., Khosla, B., Augustijns, P.F., Bradshaw, T.P., Hendren, R.W., Thakker, D.R., 1996. CYP3A-Like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells: interaction between the two biochemical barriers to intestinal transport. Drug Metab. Dispos. 24, 344-349.
|
28 |
Gottesman, M.M., Pastan, I., 1993. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, 385-427.
DOI
|
29 |
Ito, K., Kusuhara, H., Sugiyama, Y., 1999. Effects of intestinal CYP3A4 and P-glycoprotein on oral drug absorption theoretical approach. Pharm. Res. 16, 225-231.
DOI
|
30 |
Kazda, S., Garthoff, B., Krause, H.P., Schlossmann, K., 1982. Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments. Arzneimittelforschung 32, 331-338.
|
31 |
Chieli, E., Romiti, N., Cervelli, F., Tongiani, R., 1995. Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytes. Life Sci. 57, 1741-1751.
DOI
|
32 |
Cao, X., Gibbs, S.T., Fang, L., Miller, H.A., Landowski, C.P., Shin, H.C., Lennernas, H., Zhong, Y., Amidon, G.L., Yu, L.X., Sun, D., 2006. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Pharm. Res. 23, 1675-1686.
DOI
|